SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-044929
Filing Date
2019-09-17
Accepted
2019-09-17 17:04:28
Documents
1
Period of Report
2019-09-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv529604_4.html 4  
1 OWNERSHIP DOCUMENT tv529604_4.xml 4 16297
  Complete submission text file 0001144204-19-044929.txt   18869
Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 6177782500
RA Capital Healthcare Fund LP (Reporting) CIK: 0001315082 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39041 | Film No.: 191097654

Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39041 | Film No.: 191097653

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39041 | Film No.: 191097655

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Issuer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations